Arrivent Biopharma (AVBP) closed at $14.87 on October 30, 2026, down 6.8% from the previous close, on volume of 1,129,261 shares (30-day average 1,961,576).
Data as of October 30, 2026.
30-Oct-2026
Newsfile (Wed, 28-Oct 10:01 AM ET)
Market Chameleon (Mon, 26-Oct 7:01 AM ET)
Defining Moments in the Race for Biotech Breakthroughs
Globe Newswire (Mon, 26-Oct 10:44 AM ET)
Globe Newswire (Sun, 25-Oct 9:00 AM ET)
Globe Newswire (Fri, 23-Oct 4:00 PM ET)
Business Wire (Wed, 21-Oct 6:00 PM ET)
Market Chameleon (Mon, 19-Oct 7:57 AM ET)
Globe Newswire (Mon, 19-Oct 8:01 AM ET)
Globe Newswire (Tue, 13-Oct 3:42 PM ET)
ArriVent BioPharma (AVBP) Securities Investigation Notice - Levi & Korsinsky
PRNewswire (Tue, 13-Oct 3:11 PM ET)
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. The company focuses on advancing its lead product candidate, firmonertinib, for the treatment of epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC), and developing a pipeline of novel therapeutics, including next-generation antibody-drug conjugates such as ARR-217 (MRG007), with an initial focus on solid tumors.
Arrivent Biopharma trades on the NASDAQ stock market under the symbol AVBP.
As of October 30, 2026, AVBP stock price declined to $14.87 with 1,129,261 million shares trading.
AVBP has a beta of 1.03, meaning it tends to be more sensitive to market movements. AVBP has a correlation of 0.03 to the broad based SPY ETF.
AVBP has a market cap of $733.21 million. This is considered a Small Cap stock.
The top ETF exchange traded funds that AVBP belongs to (by Net Assets): VTI, XBI, IWM, VXF, VTWO.
AVBP has underperformed the market in the last year with a price return of -19.5% while the SPY ETF gained +12.3%. AVBP has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -51.5% and -10.7%, respectively, while the SPY returned +2.1% and -1.0%, respectively.
AVBP support price is $15.12 and resistance is $16.78 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AVBP shares will trade within this expected range on the day.
